RxDoctor Payments Data

Ralph Mullins, OD

Optometrist · Cookeville, TNNPI 1366425605

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $329 and has fallen 82.5% since, to $57 in 2024.

$1,262in general payments, 2019–2025

Across 48 payments — averaging $26.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$269
  • Coopervision Inc.$231
  • Alcon$197
  • AbbVie$172
  • Johnson & Johnson Vision Care, Inc.$149
  • Bausch & Lomb Americas Inc.$74
  • plus $169 from 5 others

What the payments were for

  • Food & beverage$1,22897%
  • Entertainment$343%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,262 in reported general payments places this provider in the 65th percentile of 1,122 optometrist providers in Tennessee.

See all optometrist providers in Tennessee →

Medicare billing

Part B allowed, 2024
$57,026
Medicare patients
344
Services billed
4,489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost54$425
Timolol Maleate37$230
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha12$112

Paid to pharmacies, not to this prescriber.

Other optometrist in Cookeville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →